Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial

Author:

Cornec-Le Gall Emilie12,Blais Jaime D3,Irazabal Maria V1,Devuyst Olivier4,Gansevoort Ron T5,Perrone Ron D6,Chapman Arlene B7,Czerwiec Frank S3,Ouyang John3,Heyer Christina M1,Senum Sarah R1,Le Meur Yannick2,Torres Vicente E1,Harris Peter C1

Affiliation:

1. Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55902, USA

2. European University of Western Brittany, CHU Brest, Brest, France

3. Otsuka PDC, Rockville, MD, USA

4. Institute of Nephrology, University of Zurich, Zurich, Switzerland

5. Department of Nephrology, University Medical Center of Groningen, Groningen, The Netherlands

6. Tufts Medical Center, Boston, MA, USA

7. Division of Nephrology, University of Chicago, Chicago, IL, USA

Funder

Otsuka Pharmaceutical

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3